Israel study on Pfizer vaccine indicates 94% drop in symptomatic COVID-19 cases: report
Fox News
A study by Israel’s largest healthcare provider on Sunday found that after participants received two doses of Pfizer's coronavirus vaccine, they saw a 94% drop in symptomatic COVID-19 infections, according to a report.
The study found that people in the group were also 92% less likely to develop severe illness from the virus after receiving both jabs, according to Reuters. The data nearly matched Pfizer's Phase 3 clinical trial which showed the vaccine to be 95% effective.More Related News